Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Expert Review of Pharmacoeconomics & Outcomes Research|June 17, 2009
Benefits of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosisKenneth P Johnson, Deborah L DueAnnals of Neurology|March 29, 2002
Antibody-mediated suppression of Vbeta5.2/5.3(+) T cells in multiple sclerosis: results from an MRI-monitored phase II clinical trialJoep Killestein, Tomas Olsson, Erik Wallström, et al.The Patient|January 6, 2012
Burden of a multiple sclerosis relapse: the patient's perspectiveMerrikay Oleen-Burkey, Jane Castelli-Haley, Maureen J Lage, et al.The New England Journal of Medicine|January 3, 2003
A controlled trial of natalizumab for relapsing multiple sclerosisDavid H Miller, Omar A Khan, William A Sheremata, et al.Advances in Therapy|May 16, 2009
Glatiramer acetate and interferon beta-1b: a study of outcomes among patients with multiple sclerosisJane Castelli-Haley, MerriKay A Oleen-Burkey, Maureen J Lage, et al.Journal of Neuroimmunology|July 17, 2003
Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotypeSuhayl Dhib-Jalbut, Man Chen, Areen Said, et al.Journal of the Neurological Sciences|March 3, 2007
Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trialSteven R Schwid, Andrew D Goodman, Amy Weinstein, et al.The Cochrane Database of Systematic Reviews|June 8, 2017
Focal laser treatment in addition to chemotherapy for retinoblastomaIdo D Fabian, Kenneth P Johnson, Andrew W Stacey, et al.Advances in Therapy|July 22, 2008
Glatiramer acetate versus interferon beta-1a for subcutaneous administration: comparison of outcomes among multiple sclerosis patientsJane Castelli-Haley, MerriKay Oleen-Burkey, Merry-Kay A Oleen-Burkey, et al.Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|December 4, 2018
Microperimetry and swept-source optical coherence tomography in the assessment of the preferred retinal locus in a child with macular retinoblastoma in the remaining eyeKenneth P Johnson, Aisha McLean, Gary S Rubin, et al.Pageof 3